Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.
Clinical trial NCT01056822 · COMPLETED
Trial details
- NCT number
- NCT01056822
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.